Your Money: High-risk does not necessarily translate into high returns always
If in the past, you have been successful with any investment product, you would not mind taking a further risk in the future as well. But if you have encountered unpleasant experiences with any investment, this would lead you to stay away from it.
by FE Sep 8, 2020
UTI AMC to go public next week as IPOs make a comeback
The mutual fund manager’s plan to launch its share sale comes at a time when the IPO market is seeing a revival in activity. Several other companies are also planning to go public this month.
by Mint Sep 8, 2020
5 stocks to contribute more than 50% earnings in largecaps: Nippon India MF
Market is probably being relatively complacent but we cannot take where the market is priced to perfection.
by ET Sep 8, 2020
Look at costs when index-linked insurance products are revived
Products like ETFs that are linked to an index have low costs but that may not be the case with Ilips, said experts
by Mint Sep 7, 2020
Negative SIP returns in equity mutual funds? Here's a strategy to avoid downside
If a stock falls by 75% from ₹100 to ₹25, it will need to gain 300% to recover to its original price
by Mint Sep 7, 2020
How to strike the right balance between equity and debt investments
Figuring out your equity and fixed income preferences mean that you must know how to keep them in balance. Here is how you can strike the right balance between two different asset classes of investment.
by ET Sep 7, 2020
5 new money rules for households to navigate current pandemic-hit economy
There is no cause for euphoria or the calculation that a boom is right around the corner. A period of prolonged pain, somewhat comforted by innovation in solving for the new normal, is what we should expect. But the question is how households should navigate these times.
by ET Sep 7, 2020
Five recent changes that made your debt mutual fund safer
The credit crisis which engulfed debt funds over the past two years, starting with ILFS Group default, has been exacerbated by the black swan event of COVID-related lockdown in several parts of the country over past few months.
by ET Sep 5, 2020
Earnings in pharma sector will double in 4-5 years: Sailesh Raj Bhan of Nippon India MF
Pharma is one of the sectors with high earnings visibility. Though stocks have rallied fast in the recent past, investors will earn earnings-led returns.
by ET Sep 5, 2020
Mutual funds investing in US stocks hit up to 4% in a day as Wall Street tumbles
The FAANG stocks-- Facebook, Apple, Amazon.com, Netflix and Alphabet sank between 4.6% and 6.2% in one day.
by Mint Sep 5, 2020
Emerging-market bond funds face reckoning
Assets aimed at producing higher returns in good times can post outsize losses when things go wrong.
by Mint Sep 5, 2020
Indian MFs turn to global funds for better yields, reduction of home bias
Financial planners recommend setting aside 5 to 10 per cent of one's portfolio in international funds
by BS Sep 4, 2020
Mutual funds allowed to side pocket restructured debt. Does it help investors?
Sebi has allowed mutual funds to side pocket debt in cases where borrowers have approached the mutual fund house for debt restructuring due to stress on account of Covid 19.
by Mint Sep 4, 2020
SBI Mutual Fund is bullish on this sector over 1 to 3 years
Covid19 situation has provided an opportunity to the Indian pharmaceutical industry to play an even more important role, says Tanmaya Desai, fund manager, SBI Mutual Fund.
by Mint Sep 4, 2020
Franklin Templeton's wound-up schemes receive Rs 1,500 crore in August
With this, the total cash flow into these schemes since April 24, the day of suspension, has increased to Rs 6,486 crore
by BS Sep 4, 2020
